A Study to Assess the Role of Biomarkers in Risk Stratification in Adults with Congenital Heart Disease
Rochester, MN
The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, and to determine if temporal changes in biomarker levels can provide a better risk prediction compared to biomarker assay obtained at baseline.